IQV vs XOMAP · P/E 23, rev $16.31B vs P/E 25, rev $28.5M
IQVIA Holdings Inc (IQV) versus XOMA Royalty Corporation (XOMAP) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
Not investment advice. Open the IQV and XOMAP stock pages for the full models.
Not investment advice.